Cargando…

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women

Background: Controlled pharmacokinetic (PK) studies in United States populations have defined categories of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) for various pre-exposure prophylaxis (PrEP) adherence targets. It is unknown how these categories perform in other populations. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyra, Maria, Anderson, Pete, Haberer, Jessica E., Heffron, Renee, Celum, Connie, Asiimwe, Stephen, Katabira, Elly, Mugo, Nelly R., Bukusi, Elizabeth A., Baeten, Jared M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478885/ https://www.ncbi.nlm.nih.gov/pubmed/31057407 http://dx.doi.org/10.3389/fphar.2019.00401

Ejemplares similares

Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence
por: Haberer, Jessica E., et al.
Publicado: (2017)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
por: Musinguzi, Nicholas, et al.
Publicado: (2020)

A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy
por: Heffron, Renee, et al.
Publicado: (2015)

Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention
por: Irungu, Elizabeth M., et al.
Publicado: (2016)

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa
por: Velloza, Jennifer, et al.
Publicado: (2018)

Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa
por: Heffron, Renee, et al.
Publicado: (2018)

Integrated delivery of antiretroviral treatment and pre‐exposure prophylaxis to HIV‐1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda
por: Ware, Norma C, et al.
Publicado: (2018)

Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda
por: Ying, Roger, et al.
Publicado: (2015)

Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1–Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda
por: Baeten, Jared M., et al.
Publicado: (2016)

Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women
por: Kourtis, Athena P., et al.
Publicado: (2017)

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2017)

High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
por: Matthews, Lynn T., et al.
Publicado: (2014)

Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults
por: Nickolas, Thomas L, et al.
Publicado: (2019)

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa
por: Haberer, Jessica E., et al.
Publicado: (2019)

Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples
por: Ngure, Kenneth, et al.
Publicado: (2017)

Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya
por: Kimemia, Grace, et al.
Publicado: (2019)

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2020)

Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa
por: Haberer, Jessica E., et al.
Publicado: (2013)

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya
por: Irungu, Elizabeth M., et al.
Publicado: (2019)

Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya
por: Haberer, Jessica E., et al.
Publicado: (2022)

Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study
por: Roberts, Sarah T., et al.
Publicado: (2016)

Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption
por: Mugwanya, Kenneth K., et al.
Publicado: (2016)

Health Care Worker Perspectives of HIV Pre-exposure Prophylaxis Service Delivery in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2022)

Global implementation of PrEP for HIV prevention: setting expectations for impact
por: Pyra, Maria N, et al.
Publicado: (2019)

No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda
por: Ortblad, Katrina F., et al.
Publicado: (2019)

Circumcision of Male Children for Reduction of Future Risk for HIV: Acceptability among HIV Serodiscordant Couples in Kampala, Uganda
por: Mugwanya, Kenneth K., et al.
Publicado: (2011)

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
por: Niu, Xin, et al.
Publicado: (2022)

Population pharmacokinetics of tenofovir and tenofovir‐diphosphate in healthy women
por: Burns, Rebecca N., et al.
Publicado: (2015)

Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention
por: Morton, Jennifer F., et al.
Publicado: (2017)

Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial
por: Drain, Paul, et al.
Publicado: (2020)

Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda
por: Stalter, Randy, et al.
Publicado: (2020)

Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples
por: Nakku‐Joloba, Edith, et al.
Publicado: (2019)

Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial
por: Beesham, Ivana, et al.
Publicado: (2022)

HIV prevention metrics: lessons to be learned from contraception
por: Pyra, Maria, et al.
Publicado: (2022)

Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
por: Joseph Davey, Dvora L, et al.
Publicado: (2020)

Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?()()()
por: Smith, Jennifer A., et al.
Publicado: (2017)

Perceived Social Influences on Women's Decisions to use Medications not Studied in Pregnancy. A Qualitative Ethical Analysis of Preexposure Prophylaxis Implementation Research in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2021)

The role of male partners in women’s participation in research during pregnancy: a case study from the partners demonstration project
por: Ngure, Kenneth, et al.
Publicado: (2017)

An empiric tool to identify Kenyans living with HIV who will have unsuppressed viremia 18 months following treatment initiation to guide differentiated care models
por: Njuguna, Njambi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fbrc1t7eprp7gjatniqp9c1f21